Related Experiment Video
Updated: Jun 26, 2026

Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections
Published on: March 26, 2016
Prevalence and long-term course of macro-aspartate aminotransferase in children
Maria Caropreso1, Giuliana Fortunato, Selvaggia Lenta
1Department of Pediatrics, University of Naples Federico II, Naples, Italy.
Insights
Macro-aspartate aminotransferase (macro-AST) was found in over a third of children with elevated AST. This condition appears benign in childhood, with macro-AST often persisting long-term.
Area of Science:
- Clinical Biochemistry
- Pediatric Gastroenterology
Background:
- Elevated aspartate aminotransferase (AST) levels in children can be a diagnostic challenge.
- Macro-aspartate aminotransferase (macro-AST), a complex of AST with other molecules, can cause persistent AST elevation.
- Understanding the prevalence and clinical significance of macro-AST in pediatric populations is crucial.
Purpose of the Study:
- To determine the prevalence of macro-AST in children with isolated elevated AST.
- To investigate the association of macro-AST with clinical conditions.
- To evaluate the long-term clinical and laboratory course of macro-AST in children.
Main Methods:
- Screening of 44 children with isolated elevated serum AST for macro-AST using electrophoresis and % polyethylene glycol (PEG) precipitable activity (PPA).
- Clinical and laboratory follow-up for up to 16 years.
- Analysis of AST levels and macro-AST persistence over time.
Main Results:
- Macro-AST was identified in 38.6% of the children studied.
- Children with macro-AST had significantly higher AST values compared to those without.
- Macro-AST persisted in most positive cases over long-term follow-up, while AST levels normalized in macro-AST-negative children.
Conclusions:
- Macro-AST is a common finding in children with isolated AST elevation and appears to be a benign phenomenon.
- Established %PPA thresholds can serve as an effective screening tool for macro-AST.
- Electrophoresis is recommended for confirmation and in cases with intermediate %PPA results.
Objectives:
To investigate the prevalence, association with clinical conditions, and long-term course of macro-aspartate aminotransferase (macro-AST).
Study Design:
Forty-four children with an isolated elevation of serum AST were screened for macro-AST with electrophoresis and % polyethylene glycol (PEG) precipitable activity (PPA).
Results:
All children were healthy, except they had elevated AST values. Seventeen children (38.6%) were macro-AST-positive. They had higher AST values than the 27 children who were macro-AST-negative (P = .001). Values <67.1% PPA and >82.2% PPA were associated with a very low probability of being macro-AST-positive and macro-AST-negative, respectively. Thirty-eight children underwent clinical and laboratory follow-up (mean, 4.7 +/- 3.8; range, 1-16 years). All remained symptom-free. AST levels decreased significantly only in children who were macro-AST-negative (P = .006). Macroenzyme persisted in 6 of the 9 children who were macro-AST-positive after 6.0 +/- 4.1 years.
Conclusions:
Macro-AST was present in more than one-third of children with an isolated increase of AST levels. The lack of pathological correlates in a long period argues for the benign nature of this phenomenon in childhood. We suggest that our %PPA thresholds can be used as a screening test and that electrophoresis be reserved for confirming positive screen test results and cases in which %PPA levels are of intermediate discriminant accuracy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
